CYC1 and neoplasm: Taken together with our current data, these results suggest that atovaquone treatment may be an effective new strategy for targeting the Cytochrome bc1 complex (especially MT-CYB and CYC1) in cancer, to prevent the proliferative expansion of CSCs and tumor growth.